S032 Business and Leadership: What Dermatologists Should Know
DESCRIPTION
Medicine is one of the largest businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn practical pearls for success in various aspects of Dermatology, including medical, surgical, cosmetic, and dermatopathology practice, as well as coding and billing.
LEARNING OBJECTIVES
Summarize key pearls for success in different areas of Dermatology practice, including medical, surgical, cosmetic, and dermatopathology.
Outline important pearls in coding and billing for medical and surgical Dermatology.
Recognize leadership perspectives and practical insights from experts in Dermatology and organized medicine.
SCHEDULE
1:00 PM
Pearls for Running a Successful Medical Dermatology Practice
Amy J McMichael, MD, FAAD
1:14 PM
Pearls for Running a Successful Surgical and Cosmetic Dermatology Practice
Roy G. Geronemus, MD, FAAD
1:28 PM
Pearls for Running a Successful Dermatopathology Practice
Tammie C. Ferringer, MD, FAAD
1:42 PM
Pearls in Coding and Billing for Medical Dermatology
Dirk Michael Elston, MD, FAAD
1:56 PM
Pearls in Coding and Billing for Surgical Dermatology
Howard Wooding Rogers, MD, PhD, FAAD
2:10 PM
Pearls for Starting and Running a Solo Dermatology Practice
Suzanne McGoey, MD, MPH, FAAD
2:24 PM
Pearls for Running a Successful Pediatric Dermatology Practice
2:38 PM
Pearls for Leading a Successful Dermatology Organization
Mark D. Kaufmann, MD, FAAD
2:52 PM
Pearls in Teledermatology
George Han, MD, PhD, FAAD
3:06 PM
Pearls in Artificial Intelligence Applications in Dermatology
Faranak Kamangar, MD, FAAD
3:20 PM
Leadership Pearls: Insights from a Former AMA President
Jack S. Resneck Jr., MD, FAAD
3:34 PM
How to get more involved with AAD Leadership
Marta Jane Van Beek, MD, MPH, FAAD
3:48 PM
Q&A
DIRECTOR
Keyvan Nouri, MBA, MD, FAAD
SPEAKERS
Fernanda Bellodi Schmidt, MD
Tammie C. Ferringer, MD, FAAD
Roy G. Geronemus, MD, FAAD
George Han, MD, PhD, FAAD
Faranak Kamangar, MD, FAAD
Mark D. Kaufmann, MD, FAAD
Suzanne McGoey, MD, MPH, FAAD
Amy J McMichael, MD, FAAD
Jack S. Resneck Jr., MD, FAAD
Howard Wooding Rogers, MD, PhD, FAAD
Marta Jane Van Beek, MD, MPH, FAAD
DISCLOSURES
Fernanda Bellodi Schmidt, MD
Abeona Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding);
Tammie C. Ferringer, MD, FAAD
No financial relationships exist with ineligible companies.
Roy G. Geronemus, MD, FAAD
Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);
George Han, MD, PhD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Advisory Board(Honoraria); Avillion – Investigator(Grants/Research Funding); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Celgene – Investigator(Grants/Research Funding); DermTech Inc. – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Hikma Pharmaceuticals – Speaker/Faculty Education(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); MC2 Therapeutics – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding); Othro Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Sanofi Genzyme – Speaker(Honoraria); Sonoma Pharmaceuticals – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Speaker(Honoraria); UCB – Advisory Board(Honoraria);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock Options); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock Options); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock Options);
Suzanne McGoey, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Keyvan Nouri, MBA, MD, FAAD
iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);
Jack S. Resneck Jr., MD, FAAD
No financial relationships exist with ineligible companies.
Howard Wooding Rogers, MD, PhD, FAAD
Biofrontera AG – Consultant (1099 relationship)(Fees);
Marta Jane Van Beek, MD, MPH, FAAD
No financial relationships exist with ineligible companies.